Last reviewed · How we verify
NCT05835154
A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma
NA trial testing Assessment in Metastatic Sarcoma in 20 participants. Currently enrolling.
30 April 2026
Quick facts
| Lead sponsor | Fred Hutchinson Cancer Center |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 20 |
| Start date | 8 July 2025 |
| Primary completion | 30 April 2026 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Assessment
- Questionnaire Administration
- Interview
- Electronic Health Record Review
Conditions studied
- Metastatic Sarcoma — all drugs for Metastatic Sarcoma →
- Sarcoma — all drugs for Sarcoma →
Sponsor
Fred Hutchinson Cancer Center — full company profile →
Who can join
18 and older, any sex, with Metastatic Sarcoma or Sarcoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial tests how well the advanced care planning around mobility needs checklist tool works to assess future mobility needs in patients with sarcoma. Gathering information about sarcoma patients that have had surgery to either save or remove a limb may help doctors learn more about a patient's mobility needs. Using an advance care planning mobility needs assessment may help improve the quality of life in patients with sarcoma by helping them plan for their future mobility needs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05835154
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Assessment
Trials testing the same drug.
- NCT07520981 — Functional Capacity, Subjective Dyspnea and Fatigue in Smokers · not yet recruiting
- NCT07225920 — Understanding Needs of Older Patients Prior to Starting Cancer Treatment · NA · enrolling by invitation
- NCT07249541 — Hypermobility, Foot Posture, and Scoliosis Severity · not yet recruiting
- NCT07256873 — Validity and Reliability of Face-to-Face and Tele-Assessment of Core Stability and Functional Capacity · completed
- NCT07249515 — Scapula and Upper Extremity Performance in Scoliosis · recruiting
Other recruiting trials for Metastatic Sarcoma
Currently open trials in the same condition.
- NCT04199026 — Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sa · NA · recruiting
- NCT06235125 — Safety and Feasibility of Intraoperative Visualization With Cytalux in Children · Phase 1 · recruiting
- NCT05711615 — Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Adv · Phase 1 · recruiting
- NCT04595747 — Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast · Phase 2 · active not recruiting
- NCT04693377 — Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME T · NA · recruiting
Other Fred Hutchinson Cancer Center trials
Trials by the same sponsor.
- NCT07390968 — Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Pati · Phase 2 · not yet recruiting
- NCT07493252 — A Behavioral Application for Improving Smoking Cessation Among Smokers · NA · not yet recruiting
- NCT07490860 — A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to · NA · not yet recruiting
- NCT07194980 — Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small L · Phase 2 · not yet recruiting
- NCT07176000 — Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05835154 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fred Hutchinson Cancer Center
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05835154.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing